JG
WST icon

Jefferies Group’s West Pharmaceutical WST Stock Holding History

Jefferies Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25,000
Closed -$3.55M – 3053
2019
Q3 		$3.55M Hold
25,000
– – 0.03% 709
2019
Q2 		$3.13M Hold
25,000
– – 0.02% 700
2019
Q1 		$2.75M Buy
+25,000
New +$2.6M 0.02% 731
2018
Q4 		– Sell
-9,500
Closed -$1.17M – 2635
2018
Q3 		$1.17M Buy
+9,500
New +$1.07M 0.01% 1248

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group's WST Position: Q3 2022 in Review

Jefferies Group opened a new position in West Pharmaceutical (WST) in Q3 2022: 9,874 shares worth $2.43M. The stake represents 0.02% of the portfolio and ranks #540 among its holdings. This is a return to the name: Jefferies Group previously reported a position in WST as recently as Q2 2021.

Jefferies Group first reported a position in WST in Q4 2015 and has held it in 15 quarters since. The position peaked at $6.07M in Q3 2019. 638 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Jefferies Group held 9,874 shares of West Pharmaceutical worth $2.43M as of Q3 2022.
  • West Pharmaceutical was a new Jefferies Group position in Q3 2022.
  • West Pharmaceutical made up 0.02% of Jefferies Group's portfolio in Q3 2022, its #540 holding.
  • Jefferies Group first reported a position in West Pharmaceutical in Q4 2015 and has held it in 15 quarters since.
  • Jefferies Group's West Pharmaceutical position peaked at $6.07M in Q3 2019.
  • 638 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.